Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Table of Contents:; 1 A New Way of Diagnosing -- 2 Do I Really Need This Test? -- 3 When Clinicians Disagree -- 4 The Expanded Role of Pharmacists -- 5 Better Treatment for Chronic Problems and Common Conditions -- 6 Getting Patients Engaged -- 7 The Pros and Cons of "Doctor Google" -- 8 Nurses and…
c.1 BC Cancer Agency VAN Library | Available |
Table of Contents:; Overview and theoretical framework -- What's in a word? Concepts related to sex/gender and sexuality -- The deadly effects of stigma -- Myths and facts about sexual orientation and gender identity -- Developmental transitions -- Cultures within cultures : diversity and LGBTQ co…
Etiology of lung cancer by Aage Haugen, Steen Mollerup; Epidemiology of lung cancer by Peter Boyle, Sara Gandini, Nigel Gray; Molecular biology of lung cancer by Thomas T. Poulsen, Hans S. Poulsen, Helle Pappot; Tobacco policy by Nigel Gray; Smoking cessation programs by Philip Tønnesen; Current st…
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
Contents:; Chronic Pain and Opioids -- Current Cost of the Opioid Epidemic -- Opioid Use Disorder -- History and Legality of Cannabis -- Overview of the Endocannabinoid System (ECS) -- Cannabinoids and Terpenes -- Synthetic Cannabinoid Pharmaceuticals -- Isolate Cannabinoid Pharmaceuticals -- Medic…
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Contents:; 1. Epidemiology, pathophysiology and classification -- 2. Clinical presentation -- 3. Diagnosis -- 4. Management -- 5. Treatment of associated conditions -- 6. Emerging research and treatment -- Useful resources.
Contents:; Biologics and the need for biosimilars -- Why do we need biosimilars? -- How is the quality of biosimilar medicines assured? -- Legal issues -- Switching, interchangeability and extrapolation -- Safety and pharmacovigilant -- Global issues -- Formulary considerations: pharmacy issues -- …
Contents:; Marketing Yourself as a Clinical Nurse Leader -- Integration into CNL Practice : Preparing to Lead -- Leadership Within a Complex Environment -- Microsystem Assessment and the 5P?s -- Utilizing Evidence to Improve Practice -- Utilizing Data and Quality Improvement Principles -- Coordinat…